Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Thalassemia Market Growth (Status and Outlook) 2022-2028

  • LP 4851558
  • 88 Pages
  • February 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Thalassemia will have significant change from previous year. According to our (LP Information) latest study, the global Thalassemia market size is USD million in 2022 from USD 2948.9 million in 2021, with a change of % between 2021 and 2022. The global Thalassemia market size will reach USD 5324.4 million in 2028, growing at a CAGR of 8.8% over the analysis period.

The United States Thalassemia market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Thalassemia market, reaching US$ million by the year 2028. As for the Europe Thalassemia landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Thalassemia players cover Bluebird bio, Inc., Acceleron Pharma, Inc., Celgene Corporation, and GlaxoSmithKline plc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Thalassemia market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Iron Chelating Drugs

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital

Clinic

Research Institute

Laboratories

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Bluebird bio, Inc.

Acceleron Pharma, Inc.

Celgene Corporation

GlaxoSmithKline plc

Incyte Corporation

Gamida Cell

Kiadis Pharma

La Jolla Pharmaceutical Company

IONIS Pharmaceuticals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Thalassemia Market Size 2017-2028

2.1.2 Thalassemia Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Thalassemia Segment by Type

2.2.1 Iron Chelating Drugs

2.2.2 Others

2.3 Thalassemia Market Size by Type

2.3.1 Thalassemia Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Thalassemia Market Size Market Share by Type (2017-2022)

2.4 Thalassemia Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Research Institute

2.4.4 Laboratories

2.4.5 Others

2.5 Thalassemia Market Size by Application

2.5.1 Thalassemia Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Thalassemia Market Size Market Share by Application (2017-2022)

3 Thalassemia Market Size by Player

3.1 Thalassemia Market Size Market Share by Players

3.1.1 Global Thalassemia Revenue by Players (2020-2022)

3.1.2 Global Thalassemia Revenue Market Share by Players (2020-2022)

3.2 Global Thalassemia Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Thalassemia by Regions

4.1 Thalassemia Market Size by Regions (2017-2022)

4.2 Americas Thalassemia Market Size Growth (2017-2022)

4.3 APAC Thalassemia Market Size Growth (2017-2022)

4.4 Europe Thalassemia Market Size Growth (2017-2022)

4.5 Middle East & Africa Thalassemia Market Size Growth (2017-2022)

5 Americas

5.1 Americas Thalassemia Market Size by Country (2017-2022)

5.2 Americas Thalassemia Market Size by Type (2017-2022)

5.3 Americas Thalassemia Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Thalassemia Market Size by Region (2017-2022)

6.2 APAC Thalassemia Market Size by Type (2017-2022)

6.3 APAC Thalassemia Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Thalassemia by Country (2017-2022)

7.2 Europe Thalassemia Market Size by Type (2017-2022)

7.3 Europe Thalassemia Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Thalassemia by Region (2017-2022)

8.2 Middle East & Africa Thalassemia Market Size by Type (2017-2022)

8.3 Middle East & Africa Thalassemia Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Thalassemia Market Forecast

10.1 Global Thalassemia Forecast by Regions (2023-2028)

10.1.1 Global Thalassemia Forecast by Regions (2023-2028)

10.1.2 Americas Thalassemia Forecast

10.1.3 APAC Thalassemia Forecast

10.1.4 Europe Thalassemia Forecast

10.1.5 Middle East & Africa Thalassemia Forecast

10.2 Americas Thalassemia Forecast by Country (2023-2028)

10.2.1 United States Thalassemia Market Forecast

10.2.2 Canada Thalassemia Market Forecast

10.2.3 Mexico Thalassemia Market Forecast

10.2.4 Brazil Thalassemia Market Forecast

10.3 APAC Thalassemia Forecast by Region (2023-2028)

10.3.1 China Thalassemia Market Forecast

10.3.2 Japan Thalassemia Market Forecast

10.3.3 Korea Thalassemia Market Forecast

10.3.4 Southeast Asia Thalassemia Market Forecast

10.3.5 India Thalassemia Market Forecast

10.3.6 Australia Thalassemia Market Forecast

10.4 Europe Thalassemia Forecast by Country (2023-2028)

10.4.1 Germany Thalassemia Market Forecast

10.4.2 France Thalassemia Market Forecast

10.4.3 UK Thalassemia Market Forecast

10.4.4 Italy Thalassemia Market Forecast

10.4.5 Russia Thalassemia Market Forecast

10.5 Middle East & Africa Thalassemia Forecast by Region (2023-2028)

10.5.1 Egypt Thalassemia Market Forecast

10.5.2 South Africa Thalassemia Market Forecast

10.5.3 Israel Thalassemia Market Forecast

10.5.4 Turkey Thalassemia Market Forecast

10.5.5 GCC Countries Thalassemia Market Forecast

10.6 Global Thalassemia Forecast by Type (2023-2028)

10.7 Global Thalassemia Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Bluebird bio, Inc.

11.1.1 Bluebird bio, Inc. Company Information

11.1.2 Bluebird bio, Inc. Thalassemia Product Offered

11.1.3 Bluebird bio, Inc. Thalassemia Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Bluebird bio, Inc. Main Business Overview

11.1.5 Bluebird bio, Inc. Latest Developments

11.2 Acceleron Pharma, Inc.

11.2.1 Acceleron Pharma, Inc. Company Information

11.2.2 Acceleron Pharma, Inc. Thalassemia Product Offered

11.2.3 Acceleron Pharma, Inc. Thalassemia Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Acceleron Pharma, Inc. Main Business Overview

11.2.5 Acceleron Pharma, Inc. Latest Developments

11.3 Celgene Corporation

11.3.1 Celgene Corporation Company Information

11.3.2 Celgene Corporation Thalassemia Product Offered

11.3.3 Celgene Corporation Thalassemia Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Celgene Corporation Main Business Overview

11.3.5 Celgene Corporation Latest Developments

11.4 GlaxoSmithKline plc

11.4.1 GlaxoSmithKline plc Company Information

11.4.2 GlaxoSmithKline plc Thalassemia Product Offered

11.4.3 GlaxoSmithKline plc Thalassemia Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 GlaxoSmithKline plc Main Business Overview

11.4.5 GlaxoSmithKline plc Latest Developments

11.5 Incyte Corporation

11.5.1 Incyte Corporation Company Information

11.5.2 Incyte Corporation Thalassemia Product Offered

11.5.3 Incyte Corporation Thalassemia Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Incyte Corporation Main Business Overview

11.5.5 Incyte Corporation Latest Developments

11.6 Gamida Cell

11.6.1 Gamida Cell Company Information

11.6.2 Gamida Cell Thalassemia Product Offered

11.6.3 Gamida Cell Thalassemia Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Gamida Cell Main Business Overview

11.6.5 Gamida Cell Latest Developments

11.7 Kiadis Pharma

11.7.1 Kiadis Pharma Company Information

11.7.2 Kiadis Pharma Thalassemia Product Offered

11.7.3 Kiadis Pharma Thalassemia Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Kiadis Pharma Main Business Overview

11.7.5 Kiadis Pharma Latest Developments

11.8 La Jolla Pharmaceutical Company

11.8.1 La Jolla Pharmaceutical Company Company Information

11.8.2 La Jolla Pharmaceutical Company Thalassemia Product Offered

11.8.3 La Jolla Pharmaceutical Company Thalassemia Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 La Jolla Pharmaceutical Company Main Business Overview

11.8.5 La Jolla Pharmaceutical Company Latest Developments

11.9 IONIS Pharmaceuticals

11.9.1 IONIS Pharmaceuticals Company Information

11.9.2 IONIS Pharmaceuticals Thalassemia Product Offered

11.9.3 IONIS Pharmaceuticals Thalassemia Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 IONIS Pharmaceuticals Main Business Overview

11.9.5 IONIS Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Thalassemia Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Iron Chelating Drugs

Table 3. Major Players of Others

Table 4. Thalassemia Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Thalassemia Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Thalassemia Market Size Market Share by Type (2017-2022)

Table 7. Thalassemia Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Thalassemia Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Thalassemia Market Size Market Share by Application (2017-2022)

Table 10. Global Thalassemia Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Thalassemia Revenue Market Share by Player (2020-2022)

Table 12. Thalassemia Key Players Head office and Products Offered

Table 13. Thalassemia Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Thalassemia Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Thalassemia Market Size Market Share by Regions (2017-2022)

Table 18. Americas Thalassemia Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Thalassemia Market Size Market Share by Country (2017-2022)

Table 20. Americas Thalassemia Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Thalassemia Market Size Market Share by Type (2017-2022)

Table 22. Americas Thalassemia Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Thalassemia Market Size Market Share by Application (2017-2022)

Table 24. APAC Thalassemia Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Thalassemia Market Size Market Share by Region (2017-2022)

Table 26. APAC Thalassemia Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Thalassemia Market Size Market Share by Type (2017-2022)

Table 28. APAC Thalassemia Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Thalassemia Market Size Market Share by Application (2017-2022)

Table 30. Europe Thalassemia Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Thalassemia Market Size Market Share by Country (2017-2022)

Table 32. Europe Thalassemia Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Thalassemia Market Size Market Share by Type (2017-2022)

Table 34. Europe Thalassemia Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Thalassemia Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Thalassemia Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Thalassemia Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Thalassemia Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Thalassemia Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Thalassemia Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Thalassemia Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Thalassemia

Table 43. Key Market Challenges & Risks of Thalassemia

Table 44. Key Industry Trends of Thalassemia

Table 45. Global Thalassemia Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Thalassemia Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Thalassemia Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Thalassemia Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Thalassemia Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Thalassemia Market Size Market Share Forecast by Application (2023-2028)

Table 51. Bluebird bio, Inc. Details, Company Type, Thalassemia Area Served and Its Competitors

Table 52. Bluebird bio, Inc. Thalassemia Product Offered

Table 53. Bluebird bio, Inc. Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Bluebird bio, Inc. Main Business

Table 55. Bluebird bio, Inc. Latest Developments

Table 56. Acceleron Pharma, Inc. Details, Company Type, Thalassemia Area Served and Its Competitors

Table 57. Acceleron Pharma, Inc. Thalassemia Product Offered

Table 58. Acceleron Pharma, Inc. Main Business

Table 59. Acceleron Pharma, Inc. Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Acceleron Pharma, Inc. Latest Developments

Table 61. Celgene Corporation Details, Company Type, Thalassemia Area Served and Its Competitors

Table 62. Celgene Corporation Thalassemia Product Offered

Table 63. Celgene Corporation Main Business

Table 64. Celgene Corporation Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Celgene Corporation Latest Developments

Table 66. GlaxoSmithKline plc Details, Company Type, Thalassemia Area Served and Its Competitors

Table 67. GlaxoSmithKline plc Thalassemia Product Offered

Table 68. GlaxoSmithKline plc Main Business

Table 69. GlaxoSmithKline plc Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. GlaxoSmithKline plc Latest Developments

Table 71. Incyte Corporation Details, Company Type, Thalassemia Area Served and Its Competitors

Table 72. Incyte Corporation Thalassemia Product Offered

Table 73. Incyte Corporation Main Business

Table 74. Incyte Corporation Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Incyte Corporation Latest Developments

Table 76. Gamida Cell Details, Company Type, Thalassemia Area Served and Its Competitors

Table 77. Gamida Cell Thalassemia Product Offered

Table 78. Gamida Cell Main Business

Table 79. Gamida Cell Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Gamida Cell Latest Developments

Table 81. Kiadis Pharma Details, Company Type, Thalassemia Area Served and Its Competitors

Table 82. Kiadis Pharma Thalassemia Product Offered

Table 83. Kiadis Pharma Main Business

Table 84. Kiadis Pharma Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Kiadis Pharma Latest Developments

Table 86. La Jolla Pharmaceutical Company Details, Company Type, Thalassemia Area Served and Its Competitors

Table 87. La Jolla Pharmaceutical Company Thalassemia Product Offered

Table 88. La Jolla Pharmaceutical Company Main Business

Table 89. La Jolla Pharmaceutical Company Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. La Jolla Pharmaceutical Company Latest Developments

Table 91. IONIS Pharmaceuticals Details, Company Type, Thalassemia Area Served and Its Competitors

Table 92. IONIS Pharmaceuticals Thalassemia Product Offered

Table 93. IONIS Pharmaceuticals Main Business

Table 94. IONIS Pharmaceuticals Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. IONIS Pharmaceuticals Latest Developments

List of Figures

Figure 1. Thalassemia Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Thalassemia Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Thalassemia Market Size Market Share by Type in 2021

Figure 7. Thalassemia in Hospital

Figure 8. Global Thalassemia Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Thalassemia in Clinic

Figure 10. Global Thalassemia Market: Clinic (2017-2022) & ($ Millions)

Figure 11. Thalassemia in Research Institute

Figure 12. Global Thalassemia Market: Research Institute (2017-2022) & ($ Millions)

Figure 13. Thalassemia in Laboratories

Figure 14. Global Thalassemia Market: Laboratories (2017-2022) & ($ Millions)

Figure 15. Thalassemia in Others

Figure 16. Global Thalassemia Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Thalassemia Market Size Market Share by Application in 2021

Figure 18. Global Thalassemia Revenue Market Share by Player in 2021

Figure 19. Global Thalassemia Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Thalassemia Market Size 2017-2022 ($ Millions)

Figure 21. APAC Thalassemia Market Size 2017-2022 ($ Millions)

Figure 22. Europe Thalassemia Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Thalassemia Market Size 2017-2022 ($ Millions)

Figure 24. Americas Thalassemia Value Market Share by Country in 2021

Figure 25. Americas Thalassemia Consumption Market Share by Type in 2021

Figure 26. Americas Thalassemia Market Size Market Share by Application in 2021

Figure 27. United States Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Thalassemia Market Size Market Share by Region in 2021

Figure 32. APAC Thalassemia Market Size Market Share by Application in 2021

Figure 33. China Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Thalassemia Market Size Market Share by Country in 2021

Figure 40. Europe Thalassemia Market Size Market Share by Type in 2021

Figure 41. Europe Thalassemia Market Size Market Share by Application in 2021

Figure 42. Germany Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Thalassemia Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Thalassemia Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Thalassemia Market Size Market Share by Application in 2021

Figure 50. Egypt Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Thalassemia Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Thalassemia Market Size 2023-2028 ($ Millions)

Figure 56. APAC Thalassemia Market Size 2023-2028 ($ Millions)

Figure 57. Europe Thalassemia Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Thalassemia Market Size 2023-2028 ($ Millions)

Figure 59. United States Thalassemia Market Size 2023-2028 ($ Millions)

Figure 60. Canada Thalassemia Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Thalassemia Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Thalassemia Market Size 2023-2028 ($ Millions)

Figure 63. China Thalassemia Market Size 2023-2028 ($ Millions)

Figure 64. Japan Thalassemia Market Size 2023-2028 ($ Millions)

Figure 65. Korea Thalassemia Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Thalassemia Market Size 2023-2028 ($ Millions)

Figure 67. India Thalassemia Market Size 2023-2028 ($ Millions)

Figure 68. Australia Thalassemia Market Size 2023-2028 ($ Millions)

Figure 69. Germany Thalassemia Market Size 2023-2028 ($ Millions)

Figure 70. France Thalassemia Market Size 2023-2028 ($ Millions)

Figure 71. UK Thalassemia Market Size 2023-2028 ($ Millions)

Figure 72. Italy Thalassemia Market Size 2023-2028 ($ Millions)

Figure 73. Russia Thalassemia Market Size 2023-2028 ($ Millions)

Figure 74. Spain Thalassemia Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Thalassemia Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Thalassemia Market Size 2023-2028 ($ Millions)

Figure 77. Israel Thalassemia Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Thalassemia Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Thalassemia Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450